Ritesh Indulkar / April 10, 2026 / Pharmaceuticals

Retrofitting Your Pharma Packaging Line for DSCSA Compliance Without Stopping Production

TL;DR

Downtime Fear, Not Budget, Is the Real Barrier: Most US pharmaceutical manufacturers delay DSCSA compliance due to operational risk, not cost, and that assumption is no longer justified.
Retrofitting Preserves Existing Equipment: A modular retrofit adds only the required serialization and aggregation components while leaving filling, blister, cartoning, and bottling equipment in place.
Validation Scope Stays Narrow: Because existing equipment is unchanged, IQ/OQ/PQ validation applies only to the new modules, significantly reducing project timeline and regulatory burden.
Go-Live in 10 to 12 Weeks: Jekson Vision’s structured retrofit process runs from free line assessment through FDA 21 CFR Part 11-compliant validation to operator handover within a 12-week window.
Free US Assessment Available: Qualifying US pharma manufacturers can request a no-cost line assessment from Jekson Vision’s New Jersey team to determine the minimum retrofit scope for full DSCSA compliance.

The most common reason US pharmaceutical manufacturers delay DSCSA compliance is not the budget.

It is the fear of downtime.

The assumption that achieving serialization compliance requires replacing or significantly rebuilding a packaging line is wrong and expensive.

When Jekson Vision’s US team conducts pre-installation assessments at pharma facilities across the Americas, we routinely find that most of the existing line equipment can be retained.

What changes is what gets added around it.

This article explains how a modular retrofit approach works, what it can and cannot accommodate, and how to plan a retrofit that achieves full DSCSA compliance while keeping your line running.

Table of Contents

Why Retrofitting Is the Right Approach for Most US Manufacturers

A full line replacement carries several disadvantages beyond cost:

Extended production downtime during installation and commissioning
Full revalidation of the entire line IQ, OQ, and PQ, adding months to the project timeline
Staff retraining on entirely new equipment
Risk of new equipment introducing quality issues that your existing line has eliminated over the years of operation

A modular retrofit adds only what is needed: a serialization conveyor, print-and-inspect unit, and aggregation station, while leaving your existing filling, blister, cartoning, or bottling equipment in place.

Validation scope is limited to the new components, significantly reducing time and cost.

The Retrofit Process — How Jekson Vision Does It

Step 1: Line Assessment (Week 1)

Our US engineer visits your facility, maps the existing line, identifies integration points for serialization and aggregation equipment, and defines the minimum retrofit scope needed for DSCSA compliance.

This assessment is free for qualifying US pharma manufacturers.

Step 2: Solution Design (Week 2-3)

We specify the exact REETRAK modules needed for your line.

This typically includes a serialization conveyor (S100, S103, or S105 depending on carton size and line speed), a print-and-inspect head calibrated to your existing speeds, and an aggregation station (TS200 or TS201) integrated at the case packer.

For lines requiring tamper-evident labeling, an ST200 or ST100 is added.